Is This The Right Entry Point To Add Inspire Medical Systems (INSP)?
Express News | Inspire Medical Systems, Inc. Announces the Appointment of Melissa J. Mann as Chief People Officer
Inspire Medical Systems' Implantable Inspire IV Gains EU Approval for Full-Body MRI Compatibility
Inspire Medical Systems (INSP) said Friday the European Union has approved CE marketing certification for patients with the implanted Inspire IV neurostimulator device, allowing full-body magenetic
Express News | Inspire Medical Systems, Inc. Announces Ce Mark Certification Under the European Union’s Medical Device Regulation for Inspire Therapy
Med-tech and Healthcare Stocks With Upside During 2Q Earnings - Baird
Should You Investigate Inspire Medical Systems, Inc. (NYSE:INSP) At US$146?
Inspire Medical Systems, Inc. (NYSE:INSP), might not be a large cap stock, but it saw a decent share price growth of 11% on the NYSE over the last few months. While good news for shareholders,
Express News | Inspire Medical Systems Inc : Leerink Partners Cuts Target Price to $156 From $203
Deep Dive Into Inspire Medical Systems Stock: Analyst Perspectives (6 Ratings)
Ratings for Inspire Medical Systems (NYSE:INSP) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.The table below offers a condensed view of
Inspire Medical Systems Price Target Cut to $217.00/Share From $280.00 by Truist Securities
Inspire Medical Systems Price Target Cut to $217.00/Share From $280.00 by Truist
Truist Financial Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Announces Target Price $217
Truist Financial analyst Richard Newitter maintains $Inspire Medical Systems(INSP.US)$ with a buy rating, and sets the target price at $217.According to TipRanks data, the analyst has a success rate
Express News | Inspire Medical Systems Inc : Truist Securities Cuts Target Price to $217 From $280
Truist Cuts Price Target on Inspire Medical Systems to $217 From $280, Maintains Buy Rating
Inspire Medical Systems (INSP) has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $170 to $280.
Inspire Medical Systems Is Maintained at Overweight by Morgan Stanley
Inspire Medical Systems Is Maintained at Overweight by Morgan
Inspire Medical Systems Price Target Cut to $210.00/Share From $250.00 by Morgan Stanley
Inspire Medical Systems Price Target Cut to $210.00/Share From $250.00 by Morgan
Inspire Medical Systems Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/15/2024 53.17% Morgan Stanley $250 → $210 Maintains Overweight 06/24/2024 24% Stifel $210 → $170
Morgan Stanley Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Cuts Target Price to $210
Morgan Stanley analyst Kallum Titchmarsh maintains $Inspire Medical Systems(INSP.US)$ with a buy rating, and adjusts the target price from $250 to $210.According to TipRanks data, the analyst has a
Morgan Stanley Cuts Price Target on Inspire Medical Systems to $210 From $250, Keeps Overweight Rating
Inspire Medical Systems (INSP) has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $170 to $280.
Express News | Inspire Medical Systems Inc : Mizuho Cuts Target Price to $200 From $250
Inspire Medical (INSP) Gave Back Its Gains in Q2
FDA Labels Inspire Medical's Sleep Apnea Nerve Stimulator Recall As Most Serious
The FDA has labeled a recall of Inspire Medical Systems, Inc.'s (NYSE:INSP) nerve-stimulating implant for obstructive sleep apnea as Class I, the most serious kind.Inspire initiated a recall of its